Blood test to predict cancer coming back after liver transplant
Part of Cancer, Digestive system clinical trials.
This study uses a blood test (looking at sugars in the blood) to help predict whether liver cancer will come back after a liver transplant. It may help doctors monitor you more accurately and earlier if cancer returns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to take part and sign the informed consent form
- You have been diagnosed with hepatocellular carcinoma (primary liver cancer)
- You are age 18 or older
- You are able to attend scheduled study visits and blood tests
- You are eligible for a liver transplant or currently on the transplant waiting list
- You have met with the Gastroenterology and Hepatology department
- You do not have other types of liver tumors (such as bile duct cancer or liver metastases)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a blood test (circulating tumor DNA) can help predict if hepatocellular carcinoma (HCC) will return after curative treatment like surgery or ablation. If it works, it may help doctors plan closer follow-up or earlier treatment if recurrence risk is higher.
This study looks back at medical records of people who had liver cancer (HCC) and had either a transplant or surgery to remove the tumor. It aims to improve a tool that helps predict how well a patient may do, which could guide future treatment decisions.
This trial uses a simple blood test to check for signs of liver cancer coming back after surgery. It may help doctors catch a return earlier and guide further treatment.
This study looks at two blood markers (AFP and PIVKA-II) in people getting a liver transplant for liver cancer. It aims to see if these markers can predict how well patients do after the transplant, which may help guide future treatment decisions.
This trial is testing if a blood test can find liver cancer early. It may help people who are newly diagnosed or suspected to have liver cancer and have not started treatment yet.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.